Jul 21, 2005 by Stephen D. SimpsonMerck Is No QuackProblems still abound, but the company isn't just a sitting duck.
Jul 20, 2005 by Stephen D. SimpsonStryker Delivers the GrowthStryker has been a consistent grower for years and shows no signs of slowing down.
Jul 20, 2005 by Stephen D. SimpsonPaper Giant Makes CutsInternational Paper announces a major transformative plan for its business.
Jul 20, 2005 by Stephen D. SimpsonRumors Fermenting Around DanoneTalk of a Pepsi buyout moved the shares up over 10%, but is a buyout really likely?
Jul 20, 2005 by Stephen D. SimpsonHey, Jude! Party HeartySt. Jude's ICD business is on fire and fueling strong profit growth for this medical device maker.
Jul 20, 2005 by Stephen D. SimpsonWhy Not Wyeth?Wyeth has turned itself around, but is it still an attractive big-pharma investment?
Jul 20, 2005 by Stephen D. SimpsonPfizer's Long Road BackIt took time for Pfizer to reach a trough and it will take time to climb out.
Jul 20, 2005 by Stephen D. SimpsonA Stock Junkie in Fund LandEven hard-core equity investors can, and should, find a place in their portfolios for the right mutual fund.
Jul 20, 2005 by Stephen D. SimpsonIs United Technologies Underappreciated?Despite a solid collection of businesses, United Technologies hasn't always gotten a lot of love.
Jul 20, 2005 by Stephen D. SimpsonOn the Right Canadian TrackCanadian National Railway continues to reap the benefits of a strong railroad market.
Jul 20, 2005 by Stephen D. SimpsonKeep Your Seat Belts FastenedContinental's better-than-expected profit for the second quarter is good news, but does that make this a good stock?
Jul 20, 2005 by Stephen D. SimpsonTwo Ways to Play RocheTrying to track Roche is a pain, so investors might want to think about Genentech instead.
Jul 20, 2005 by Stephen D. SimpsonCymer Investors Light UpBetter-than-expected results boost the stock, but the near-term outlook is still murkey.
Jul 19, 2005 by Stephen D. SimpsonWachovia Gets the Edge -- AgainSolid growth, improving efficiency, and a reasonable valuation may spell opportunity.
Jul 19, 2005 by Stephen D. SimpsonPeek-a-Boo ICUICU Medical has taken on quite a bit of risk in the process of remaking the company.
Jul 19, 2005 by Stephen D. SimpsonA Clearing in the Forest?Despite so-so results, the biotech stock's slide may finally be over.
Jul 19, 2005 by Stephen D. SimpsonSarbanes Pain Is Resources Connection's GainGreater demand for compliance assistance has boosted this financial-services firm.
Jul 19, 2005 by Stephen D. SimpsonWaiting for Boston Scientific's Second ActThe market for drug-coated stents is still lucrative, but BSX needs to deliver on its R&D efforts for long-term success.
Jul 19, 2005 by Stephen D. SimpsonDynamic Times Ahead?Business is tough now, but a prolonged boom in commercial construction would be a boon for Steel Dynamics.
Jul 19, 2005 by Stephen D. SimpsonPeabody's Money PitStrong demand and low inventories have kept coal prices buoyant, allowing Peabody to rake in the cash.
